[ Price : $8.95]
FDA recommends that companies making transmucosal buprenorphine drugs indicated to treat opioid dependence revise the labeling to ...[ Price : $8.95]
FDA publishes an updated Global Unique Device Identification Database guidance.[ Price : $8.95]
Axsome Therapeutics plans an NDA submission for AXS-05 (dextromethorphan-bupropion) in the second half of next year for treating A...[ Price : $8.95]
Novo Nordisk petitions FDA to exclude its liraglutide from the agencys list of bulk drug substances that may be used by drug compo...[ Price : $8.95]
FDA posts a six-item Form FDA-483 that led to a 12/19 Warning Letter to Mylan Laboratories citing its Pradesh, India manufacturing...[ Price : $8.95]
FDA approves Checkpoint Therapeutics Unloxcyt to treat some squamous cell cancer patients.[ Price : $8.95]
FDA approves Xcoverys Ensacove, an anaplastic lymphoma kinase inhibitor, to treat some non-small cell lung cancers.[ Price : $8.95]
FDA approves Humacytes Symvess for use with some extremity arterial injuries.